Fifth Third Bancorp’s Tvardi Therapeutics TVRD Stock Holding History

Fifth Third Bancorp’s Portfolio TVRD Stock Details TVRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3	Buy	+1	New	+$4	﹤0.01%	4301
2023 Q2	–	Sell	-15	Closed	-$2.64K	–	2791
2023 Q1	$2.64K	Buy	+15	New	+$5.02K	﹤0.01%	2506
2021 Q4	–	Sell	-1	Closed	–	–	2814
2021 Q3	$0	Buy	+1	New	+$502	﹤0.01%	2773
2021 Q2	–	Sell	-24	Closed	-$19K	–	2550
2021 Q1	$19K	Hold	24	–	–	﹤0.01%	1804
2020 Q4	$13K	Hold	24	–	–	﹤0.01%	1848
2020 Q3	$11K	Hold	24	–	–	﹤0.01%	1756
2020 Q2	$15K	Hold	24	–	–	﹤0.01%	1638
2020 Q1	$11K	Buy	+24	New	+$13K	﹤0.01%	1695

Other funds holding TVRD

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AFG

American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DWAM

Duncan Williams Asset Management Memphis, Tennessee $361M AUM 18% 1-Year Est. Return

Fifth Third Bancorp's TVRD Position: Q1 2026 in Review

Fifth Third Bancorp opened a new position in Tvardi Therapeutics (TVRD) in Q1 2026: 1 share worth $3. The stake represents ﹤0.01% of the portfolio and ranks #4301 among its holdings. This is a return to the name: Fifth Third Bancorp previously reported a position in TVRD as recently as Q1 2023.

Fifth Third Bancorp first reported a position in TVRD in Q1 2020 and has held it in 8 quarters since. The position peaked at $19K in Q1 2021. 67 funds tracked by Wall St. Rank hold TVRD as of Q1 2026.

Fifth Third Bancorp held 1 share of Tvardi Therapeutics worth $3 as of Q1 2026.
Tvardi Therapeutics was a new Fifth Third Bancorp position in Q1 2026.
Tvardi Therapeutics made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q1 2026, its #4301 holding.
Fifth Third Bancorp first reported a position in Tvardi Therapeutics in Q1 2020 and has held it in 8 quarters since.
Fifth Third Bancorp's Tvardi Therapeutics position peaked at $19K in Q1 2021.
67 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.